BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

896 related articles for article (PubMed ID: 19285987)

  • 21. Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization.
    Yuan W; Parrish CR
    Virology; 2000 Apr; 269(2):471-80. PubMed ID: 10753725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling.
    Hou S; Li B; Wang L; Qian W; Zhang D; Hong X; Wang H; Guo Y
    J Biochem; 2008 Jul; 144(1):115-20. PubMed ID: 18424812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
    Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humanization of chicken monoclonal antibody using phage-display system.
    Nishibori N; Horiuchi H; Furusawa S; Matsuda H
    Mol Immunol; 2006 Feb; 43(6):634-42. PubMed ID: 16360012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
    Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
    J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
    Hoet RM; Cohen EH; Kent RB; Rookey K; Schoonbroodt S; Hogan S; Rem L; Frans N; Daukandt M; Pieters H; van Hegelsom R; Neer NC; Nastri HG; Rondon IJ; Leeds JA; Hufton SE; Huang L; Kashin I; Devlin M; Kuang G; Steukers M; Viswanathan M; Nixon AE; Sexton DJ; Hoogenboom HR; Ladner RC
    Nat Biotechnol; 2005 Mar; 23(3):344-8. PubMed ID: 15723048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.
    Simmons DP; Streltsov VA; Dolezal O; Hudson PJ; Coley AM; Foley M; Proll DF; Nuttall SD
    Proteins; 2008 Apr; 71(1):119-30. PubMed ID: 17932913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Characterization of a panel of mouse single-chain antibodies against recombinant human interferon beta1b].
    Pavlova MV; Nikolaev IuS; Irodov DM; Okunev OV; Kordium VA; Gil'chuk PV
    Tsitol Genet; 2008; 42(4):3-11. PubMed ID: 19140425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
    Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
    Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Framework residues 71 and 93 of the chimeric B72.3 antibody are major determinants of the conformation of heavy-chain hypervariable loops.
    Xiang J; Sha Y; Jia Z; Prasad L; Delbaere LT
    J Mol Biol; 1995 Oct; 253(3):385-90. PubMed ID: 7473721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evolution of single-chain antibodies using mRNA display.
    Fukuda I; Kojoh K; Tabata N; Doi N; Takashima H; Miyamoto-Sato E; Yanagawa H
    Nucleic Acids Res; 2006; 34(19):e127. PubMed ID: 17012279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity maturation of a novel antagonistic human monoclonal antibody with a long VH CDR3 targeting the Class A GPCR formyl-peptide receptor 1.
    Douthwaite JA; Sridharan S; Huntington C; Hammersley J; Marwood R; Hakulinen JK; Ek M; Sjögren T; Rider D; Privezentzev C; Seaman JC; Cariuk P; Knights V; Young J; Wilkinson T; Sleeman M; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2015; 7(1):152-66. PubMed ID: 25484051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1.
    Koti M; Farrugia W; Nagy E; Ramsland PA; Kaushik AK
    Mol Immunol; 2010 Feb; 47(5):953-60. PubMed ID: 20006385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody humanization by framework shuffling.
    Dall'Acqua WF; Damschroder MM; Zhang J; Woods RM; Widjaja L; Yu J; Wu H
    Methods; 2005 May; 36(1):43-60. PubMed ID: 15848074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humanization by variable domain resurfacing and grafting on a human IgG4, using a new approach for determination of non-human like surface accessible framework residues based on homology modelling of variable domains.
    Staelens S; Desmet J; Ngo TH; Vauterin S; Pareyn I; Barbeaux P; Van Rompaey I; Stassen JM; Deckmyn H; Vanhoorelbeke K
    Mol Immunol; 2006 Mar; 43(8):1243-57. PubMed ID: 16118019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and fluorescence studies of affinity maturation in related antibodies.
    Pauyo T; Hilinski GJ; Chiu PT; Hansen DE; Choi YJ; Ratner DI; Shah-Mahoney N; Southern CA; O'Hara PB
    Mol Immunol; 2006 Mar; 43(7):812-21. PubMed ID: 16137768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting.
    Balyasnikova IV; Berestetskaya JV; Visintine DJ; Nesterovitch AB; Adamian L; Danilov SM
    Microvasc Res; 2010 Dec; 80(3):355-64. PubMed ID: 20888351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Construction and characterization of a high-affinity humanized SM5-1 monoclonal antibody.
    Li B; Wang H; Zhang D; Qian W; Hou S; Shi S; Zhao L; Kou G; Cao Z; Dai J; Guo Y
    Biochem Biophys Res Commun; 2007 Jun; 357(4):951-6. PubMed ID: 17451647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.